Antibiotic resistance of Helicobacter pylori in Mashhad, Iran

Journal of the Pakistan Medical Association

Volumn 63, Issue 3, 2013, Pages 336-339

  Zendedel, Abolfazl ^a   Moradimoghadam, Farideh ^b   Almasi, Vahid ^a   Zivarifar, Hamidreza ^b  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic; Antibiotic resistance; Helicobacter pylori

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; TRIMETHOPRIM; UREASE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BIOPSY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; ENDOSCOPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; CHI-SQUARE DISTRIBUTION; CLARITHROMYCIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MICROBIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; METRONIDAZOLE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TETRACYCLINE; UREASE;

EID: 84874610763     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alimoradi J, Rasmussen L, Andersen LP. Helicobacter pylori resistance. Ugeskr Laeger 2010; 172: 1516-21.
2. Mégraud F. Helicobacter pylori infection: Review and practice. Presse Med 2010; 39: 815-22.
3. Bago J, Majstorovi K, Belosi-Halle Z, Kuisec N, Bakula V, Tomi M, et al. Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial. Ann Clin Microbiol Antimicrob 2010; 9: 13.
4. Pandey R, Misra V, Misra SP, Dwivedi M, Kumar A, Tiwari BK. Helicobacter pylori and gastric cancer. Asian Pac J Cancer Prev 2010; 11: 583-8.
5. Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol 2010; 5: 639-48.
6. Raymond J, Lamarque D, Kalach N, Chaussade S, Burucoa C. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010; 15: 21-7.
7. Naja F, Kreiger N, Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007; 21: 501-6.
8. Nguyen TL, Uchida T, Tsukamoto Y, Trinh DT, Ta L, Mai BH, et al. Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol 2010; 10: 114.
9. Furuta T, Graham DY. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am 2010; 39: 465-80.
10. Romano M, Cuomo A, Gravina AG, Miranda A, Iovene MR, Tiso A, et al. Empirical levofloxacin-containing versus clarithromycincontaining sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010; 59: 1465-70.
11. Tanih NF, Okeleye BI, Naidoo N, Clarke AM, Mkwetshana N, Green E, et al. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications. S Afr Med J 2010; 100: 49-52.
12. Boyanova L, Ilieva J, Gergova G, Spassova Z, Nikolov R, Davidkov L, et al. Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria. J Med Microbiol 2009; 58: 94-100.
13. Ben Mansour K, Burucoa C, Zribi M, Masmoudi A, Karoui S, Kallel L, et al. Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob 2010; 9: 22.
14. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010; 19: 409-14.
15. Siavoshi F, Saniee P, Latifi-Navid S, Massarrat S, Sheykholeslami A. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies. Arch Iran Med 2010; 13: 177-87.
16. Sun QJ, Liang X, Zheng Q, Gu WQ, Liu WZ, Xiao SD, et al. Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol 2010; 16: 5118-21.
17. Gao W, Cheng H, Hu F, Li J, Wang L, Yang G, et al. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. Helicobacter 2010; 15: 460-6.
18. Sánchez Ceballos F, Taxonera Samsó C, García Alonso C, Alba López C, Sainz de Los Terreros Soler L, Díaz-Rubio M. Prevalence of Helicobacter pylori infection in the healthy population of Madrid. Rev Esp Enferm Dig 2007; 99: 497-501.
19. O'connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, et al. Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland. Eur J Gastroenterol Hepatol 2010; 22: 1123-7.
20. Talebi Bezmin Abadi A, Mobarez AM, Taghvaei T, Wolfram L. Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter 2010; 15: 505-9.
21. Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroenterol 2010; 16: 5746-51.